In letteratura, le dosi utilizzate negli studi clinici sono differenti, e per questo fondamentale non affidarsi al fai-da-te ma chiedere sempre consiglio a un professionista
Because these therapies include both GLP-1 and GIP receptor agonists, our weight loss medications can offer superior appetite suppression and metabolic benefits compared to GLP 1 alone
10.3389/fphar.2018.00544 255
Furthermore, the increased emphasis on expanding therapeutic applications of GLP-1 receptor agonists (GLP-1 RAs) with ongoing research activities in various fields for developing potential applications like in cardiovascular diseases for prevention and management of heart attacks and strokes, for reducing progression of chronic kidney disease (CKD), in neurodegenerative diseases as well as for anti-inflammatory and anti-infection effects are expected to drive the market growth
Intended setting: Laboratory research use only
Martnez Leo EE, Meza Peafiel A, Hernndez Escalante VM, Cabrera Araujo ZM